(90)Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy

Pretherapy PET with (86)Y-DOTATOC is considered the ideal dosimetry protocol for (90)Y-DOTATOC therapy; however, its cost, limited availability, and need for infusion of amino acids to mimic the therapy administration limit its use in the clinical setting. The goal of this study was to develop a dos...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Nucl Med
Glavni autori: Menda, Yusuf, Madsen, Mark T., O’Dorisio, Thomas M., Sunderland, John J., Watkins, G. Leonard, Dillon, Joseph S., Mott, Sarah L., Schultz, Michael K., Zamba, Gideon K.D., Bushnell, David L., O’Dorisio, M. Sue
Format: Artigo
Jezik:Inglês
Izdano: Society of Nuclear Medicine 2018
Teme:
Theranostics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6225542/
https://ncbi.nlm.nih.gov/pubmed/29523629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.202903
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items